Urinary Catheters Industry Outlook, Research, Trends and Forecast to 2030

 The global urinary catheters market was valued at USD 5.2 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2030. This growth is driven by an increasing number of patients experiencing Urinary Tract Infections (UTIs), urethral blockages, and tumors in the urinary tract or reproductive organs, along with the rapidly expanding geriatric population. Urinary catheters, which are flexible tubes used to drain urine from the bladder, are commonly made from materials such as plastic, rubber, and silicon. Physicians recommend urinary catheterization for conditions such as Urinary Incontinence (UI), urinary retention, prostate surgery, or other medical issues like spinal cord injury, multiple sclerosis, or dementia, where bladder function may be compromised.

Gather more insights about the market drivers, restrains and growth of the Urinary Catheters Market

Regional Insights:

North America Urinary Catheters Market Trends

North America led the global urinary catheters market in 2022, holding over 34.4% of the total revenue share, with expected continued growth. This dominance is attributed to the increasing prevalence of diseases such as bladder obstruction, UI, Benign Prostate Hyperplasia (BPH), urinary retention, and bladder cancer. In North America, urological conditions are a significant health concern, especially among the elderly. The National Association for Continence reports that individuals aged 40 and above frequently suffer from Overactive Bladder (OAB) and urine urgency. Additionally, the American Society of Nephrology notes that urologic issues rank as the third most common complaint in individuals aged 65 and above, accounting for about 47% of physician visits in the U.S. Furthermore, bladder cancer rates are significant; according to the Canadian Cancer Society, around 12,200 cases were diagnosed in 2020, with 2,600 related deaths. The high incidence of BPH-related surgeries and rising bladder cancer cases are key factors driving market growth in North America.

Asia Pacific Urinary Catheters Market Trends

The Asia Pacific region is projected to be the fastest-growing market for urinary catheters during the forecast period. This growth is fueled by the increasing incidence of spinal cord injuries, BPH, and UTIs, with UTIs being among the most prevalent infectious diseases in the region. UTIs in Asia Pacific lead to high rates of morbidity and mortality, especially in hospitals, and impose a considerable financial burden on communities. Factors like advancing age, constipation, vaginal deliveries, childbirth, obesity, surgery, and chronic respiratory conditions elevate the risk of UTIs, particularly among women, thereby driving demand for urinary catheters in the region. Additionally, increased government spending, investments by leading market players, and awareness initiatives are expected to contribute to market growth. For example, in India, the Urological Society of India developed guidelines to raise awareness about urinary incontinence, while in South Korea, the Korean Incontinence Society promotes awareness regarding pelvic floor and lower urinary tract health issues. Such initiatives are anticipated to drive market expansion in Asia Pacific throughout the forecast period.

Browse through Grand View Research's Category Medical Devices Industry Research Reports.

• The global endoscope sterilization market size was estimated at USD 1.20 billion in 2024 and is projected to grow at a CAGR of 9.64% from 2025 to 2030.
• The global neuromodulation devices market size was estimated at USD 5,795.81 million in 2024 and is anticipated to grow at a CAGR of 8.51% from 2025 to 2030.

Key Companies & Market Share Insights:

To expand their market share, companies in the urinary catheters industry are continuously introducing new products and expanding their geographical reach. For instance, Japan-based Terumo Corporation acquired Sequent Medical, a U.S.-based medical device manufacturer, through its U.S. subsidiary. This acquisition reflects a broader trend among global players, who are relocating production facilities to different countries to achieve economies of scale.

Furthermore, many manufacturers in the catheter industry form partnerships with major medical device distributors to supply their products either globally or within specific countries. Such strategic alliances are widespread and benefit manufacturers by providing marketing licenses, while also reducing liability in cases of product recall or adverse events. A prominent example is the three-year purchasing agreement signed in March 2019 between Coloplast Corporation and Premier Inc., a U.S.-based healthcare company. Through this agreement, Coloplast’s urology products, including catheters, gained access to Premier’s network alliance, which consists of around 4,000 U.S. hospitals. Premier's integrated supply chain, advisory, and data analytics solutions allow Coloplast to secure supply agreements at lower costs, supporting the company’s market presence and reach in the U.S.

Key Urinary Catheters Companies:

• Hollister, Inc.
• Medtronic PLC
• Boston Scientific Corp.
• BD (C.R. Bard, Inc.)
• Cook Medical
• ConvaTec, Inc.
• Teleflex, Inc.
• Coloplast
• Braun Melsungen AG
• Medline Industries, Inc.
• J and M Urinary Catheters LLC

Order a free sample PDF of the Urinary Catheters Market Intelligence Study, published by Grand View Research.

Urinary Catheters Industry 2030 Revenue, Top Key Drivers by Manufacturers and Outlook

 The global urinary catheters market was valued at USD 5.2 billion in 2022, and it is projected to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2030. This growth is primarily driven by several key factors, including an increase in the number of patients experiencing Urinary Tract Infections (UTIs) and blockages in the urethra. Additionally, rising incidences of tumors affecting the urinary tract or reproductive organs, coupled with the rapidly aging global population, are also contributing to the expansion of the market. A urinary catheter is a partially flexible tube designed to drain urine from the bladder, and it is commonly made from materials such as plastic, rubber, and silicone. Medical professionals recommend urinary catheters for conditions such as Urinary Incontinence (UI), urinary retention, prostate surgeries, or in cases where patients suffer from spinal cord injuries, multiple sclerosis, or dementia.

Gather more insights about the market drivers, restrains and growth of the Urinary Catheters Market

Impact of COVID-19 on the Market:

The COVID-19 pandemic is expected to have a positive impact on the urinary catheter market. According to data from the National Center for Biotechnology Information (NCBI), the use of catheters, including urinary and central line catheters, saw an increase during the COVID-19 outbreak. For instance, in 2020, the Standardized Utilization Ratio (SUR) for urinary catheters increased by 7.4%, rising from 0.79 before the pandemic to 0.84 during the outbreak. Similarly, the SUR for central line catheters rose by 4.9%, from 0.88 pre-pandemic to 0.92 during the crisis. This increased demand for catheters, especially in critical care settings, is expected to contribute to the market's growth over the forecast period.

The pandemic also underscored the importance of infection prevention, leading to innovations in catheter technology. Several manufacturers have responded to the heightened awareness of infection control by developing products like coated urinary catheters with built-in temperature monitoring capabilities. These advancements are aimed at reducing the risk of secondary infections in critically ill patients. For instance, in February 2021, Health Canada approved Bactiguard's urinary catheter with a temperature sensor for infection prevention. This approval was expedited due to the urgency created by the pandemic, as these catheters have shown the potential to lower secondary infection rates, thereby supporting market growth.

Product Segmentation Insights:

In 2022, the intermittent catheter segment led the urinary catheters market, accounting for over 57.5% of total revenue. Intermittent catheters are medical devices used to intermittently drain the bladder. These catheters are considered a superior alternative to indwelling (continuous) catheters, which are more likely to lead to UTIs. Intermittent catheterization is often recommended for patients with spinal cord injuries or neurogenic bladder issues. As a result, these devices are considered the gold standard for bladder management in such cases. The availability of reimbursement for intermittent catheters under programs like Medicaid and Medicare has further contributed to the growth of this market segment.

The fastest-growing product segment is expected to be external catheters over the forecast period. These catheters are primarily used for male patients and offer a less invasive alternative to indwelling catheters, which must be inserted through the urethra. External catheters are also popular among patients who prefer to self-catheterize, especially in cases of UI or urinary retention. Additionally, these catheters come in a range of styles and sizes, providing patients with various options to suit their individual needs. Leading companies in the industry are offering advanced external catheter products. For example, BD (C.R. Bard) manufactures the ULTRAFLEX male external catheter, which features a more secure fit compared to traditional non-silicone sheaths, providing users with greater comfort and reliability.

Order a free sample PDF of the Urinary Catheters Market Intelligence Study, published by Grand View Research.